Gilead Halts 6 Zydelig Trials After Deaths
By Jeff Overley · March 14, 2016, 6:27 PM EDT
Gilead Sciences Inc. is halting six clinical trials involving the cancer drug Zydelig after patient deaths occurred, the U.S. Food and Drug Administration said late Monday....
To view the full article, register now.